Pharma IQ Members

Pre-Clinical (Discovery and Development)

Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.

523 results
of 48
Contributor: Chanice Henry
Posted: Mon, 04/23/2018
Similar to new Hollywood feature Rampage, a recent study has urged the life sciences industry not to underestimate the dangers that could hide within CRISPR Cas9. Full Content »
Contributor: Chanice Henry
Posted: Mon, 04/16/2018
Nashville Biosciences -Vanderbilt University Medical Center
To fast-track the development of innovative medicines, a biotech start-up is opening access to its extensive genomic and bioinformatics resources. Full Content »
Contributor: Pharma IQ News
Posted: Mon, 04/09/2018
Pills thumb
These pharma and medical podcasts allow you to digest the latest inspiring discoveries and developments in medicine and healthcare Full Content »
Contributor: Pharma IQ News
Posted: Mon, 03/19/2018
Pharma IQ News
Trailblazing simulations and nanotechnology projects are improving cancer treatments and preventing late stage attrition. Full Content »
Contributor: Pharma IQ News
Posted: Mon, 03/12/2018
Pharma IQ News
The EMA is driving the move away from medical animal testing in the pharmaceutical and biologics industries. Full Content »
Contributor: Dr. Gerhard Noelken
Posted: Fri, 03/09/2018
Wearables data medical
The pharmaceutical industry is looking at its vast reserves of data for actionable insights to inform drug discovery. Full Content »
Contributor: Pharma IQ News
Posted: Fri, 02/16/2018
As well as saving millions of lives, a new study forecasts a suite of vaccines will have an enormous impact on keeping people out of poverty. Full Content »
Contributor: Katie Sadler
Posted: Wed, 02/14/2018
Katie Sadler bw
Around 90 per cent of the world’s data was generated in the past two years alone, presenting the biomedical sector with a significant challenge, said Professor Jackie Hunter Full Content »
Contributor: Pharma IQ News
Posted: Tue, 02/06/2018
Researchers have managed to eliminate distant cancerous growths in mice by activating T-cells in tumors. Full Content »
Posted: Fri, 02/02/2018
Regulatory authorities like the FDA and MHRA expect pharma labs to keep current with technology and improve how they safeguard drug quality. GMP compliance can absorb a lot of time and resources, but slip-ups are costly. Some labs know this all too well after receiving an investigator warning letter or finding. Full Content »
523 results
of 48